Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2013 Dec;57(12):6406–6408. doi: 10.1128/AAC.01773-13

High Prevalence of Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae in Poultry Meat in Switzerland: Emergence of CMY-2- and VEB-6-Possessing Proteus mirabilis

Salome N Seiffert a,b,c,, Regula Tinguely a, Agnese Lupo a, Catherine Neuwirth d, Vincent Perreten b, Andrea Endimiani a
PMCID: PMC3837880  PMID: 24080656

LETTER

The spread of extended-spectrum-cephalosporin-resistant (ESC-R) Escherichia coli in poultry meat is a serious concern (13). However, data regarding this problem in Switzerland are lacking. Moreover, the role played in this matter by other Enterobacteriaceae remains undetermined.

We explored the prevalence of extended-spectrum-β-lactamase (ESBL)- and plasmid-mediated-AmpC (pAmpC)-possessing Enterobacteriaceae as contaminants of raw poultry meat retailed in Bern, Switzerland. Twenty samples were purchased on various days during November and December 2012 in three grocery stores (Table 1). Ten grams of meat was incubated overnight in LB broth, and then 50 μl was plated on plates containing selective chromID ESBL agar, MacConkey agar plus ceftazidime (2 μg/ml), and Drigalski agar plus cefotaxime (1.5 μg/ml) (bioMérieux). Colonies were identified by MALDI-TOF MS (matrix-assisted laser desorption ionization–time of flight mass spectrometry; Bruker). ESC-R Enterobacteriaceae were characterized using phenotypic and molecular methods as previously done (47) (see Table S1 in the supplemental material).

Table 1.

Phenotypic and molecular characteristics of the blaESBL- and blapAmpC-possessing E. coli and P. mirabilis isolates found in poultry meat retailed in Bern during the study perioda

Meat (store) Species blaESBL, blapAmpC Plasmid Inc group(s) Phylogenetic group ST Antimicrobial agents tested (MICs, μg/ml)b Countryc
Production Packaging (packing plant)
Turkey slices (A) E. coli CMY-2 F, A/C D ST117 CTX (4), CAZ (4), FEP (≤1), ATM (4), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≤0.25), COL (≤0.125), TGC (≤0.125) GER GER (I)
Turkey slices (A) GER GER (I)
Chicken slices (A) E. coli SHV-12, TEM-1 F, X1 B1 ST155 CTX (2), CAZ (8), FEP (≤1), ATM (≥32), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≥8), COL (≤0.125), TGC (≤0.125) GER GER (Un)
Chicken slices (A) E. coli TEM-52 F, I1, X1 A ST23 CTX (4), CAZ (4), FEP (≤1), ATM (≤1), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≤0.25), COL (≤0.125), TGC (≤0.125) GER GER (Un)
Chicken ministeaks (A) E. coli CTX-M-1 F, I1 D ST2485 CTX (≥64), CAZ (2), FEP (4), ATM (8), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≥8), COL (≤0.125), TGC (≤0.125) CH CH (II)
Chicken ministeaks (A) CH CH (II)
Ground chicken (A) E. coli CTX-M-1, TEM-1 F, FII, I1 A ST1141 CTX (16), CAZ (≤0.5), FEP (4), ATM (4), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≥8), COL (≤0.125), TGC (≤0.125) CH CH (II)
Chicken legs (A) CH CH (II)
Ground chicken (A) E. coli CTX-M-1 F, I1 B1 ST602 CTX (8), CAZ (≤0.5), FEP (≤1), ATM (4), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≥8), COL (≤0.125), TGC (≤0.125) CH CH (II)
Chicken legs (A) CH CH (II)
Chicken wings (B) E. coli CTX-M-1 F B1 ST1304 CTX (16), CAZ (≤0.5), FEP (≤1), ATM (4), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≤0.25), COL (≤0.125), TGC (≤0.125) CH CH (III)
Chicken wings (B) CH CH (III)
Chicken legs (B) E. coli CMY-2 F, B/O, A/C, K D ST38 CTX (8), CAZ (8), FEP (≤1), ATM (4), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≤0.25), COL (≤0.125), TGC (≤0.125) CH CH (III)
Chicken wings (B) E. coli CTX-M-1 I1, Y D ST2485 CTX (16), CAZ (≤0.5), FEP (4), ATM (8), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≥8), COL (≤0.125), TGC (≤0.125) CH CH (III)
Ground chicken breasts (B) E. coli SHV-12 F, FII, I1 B1 ST155 CTX (2), CAZ (8), FEP (≤1), ATM (16), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≤0.25), COL (≤0.125), TGC (≤0.125) AUT CH (III)
P. mirabilis CMY-2 I1 NA NA CTX (2), CAZ (4), FEP (≤1), ATM (≤1), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (2), AMK (8), CIP (≤0.125), SXT (≤0.25), COL (≥8), TGC (2)
Turkey slices (C) P. mirabilis VEB-6, TEM-1d P NA NA CTX (16), CAZ (≥32), FEP (8), ATM (8), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≥16), AMK (16), CIP (≥4), SXT (≥8), COL (≥8), TGC (2) EU CH (IV)
Turkey slices (C) P. mirabilis VEB-6, TEM-1d P NA NA CTX (16), CAZ (≥32), FEP (16), ATM (8), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (8), AMK (16), CIP (≥4), SXT (≥8), COL (≥8), TGC (2) EU CH (IV)
Ground chicken (C) E. coli CTX-M-1 F, I1, P, U A ST23 CTX (16), CAZ (≤0.5), FEP (≤1), ATM (4), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≥8), COL (≤0.125), TGC (≤0.125) CH CH (V)
Chicken ministeaks (C) CH CH (V)
Chicken slices (C) E. coli CTX-M-1 F, I1 A ST23 CTX (32), CAZ (≤0.5), FEP (4), ATM (4), TZP (≤4), MEM (≤0.5), ERT (≤0.125), GEN (≤0.5), AMK (≤2), CIP (≤0.125), SXT (≥8), COL (≤0.125), TGC (≤0.125) CH CH (V)
a

—, isolates possessing blaESBLs or blaaAmpCs were not detected. NA, not applicable.

b

Antibiotics and interpretation of MICs according to EUCAST criteria (14) were as follows: CTX, cefotaxime (susceptible [S], ≤ 1 μg/ml); CAZ (S, ≤ 1 μg/ml); FEP, cefepime (S,≤ 1 μg/ml); ATM, aztreonam (S, ≤ 1 μg/ml); TZP, piperacillin-tazobactam (S, ≤ 8 μg/ml); MEM, meropenem (S, ≤ 2 μg/ml); ERT, ertapenem (S, ≤ 0.5 μg/ml); GEN, gentamicin (S, ≤ 2 μg/ml); AMK, amikacin (S, ≤ 8 μg/ml); CIP, ciprofloxacin (S, ≤ 0.5 μg/ml); SXT (S, ≤ 2 μg/ml); COL, colistin (S, ≤ 2 μg/ml); TGC, tigecycline (S, ≤ 1 μg/ml). MICs were determined by using GNX2F plates (Trek Diagnostics).

c

GER, Germany; CH, Switzerland; AUT, Austria; EU, European Union (the country was not specified on the package sticker). I, II, III, IV, V, and Un (unknown) indicate the different meat-packing plants.

d

Both isolates possessed the following non-bla resistance genes according to the AMR-ve 0.5-m microarray (Alere): blaVEB, blaTEM, aadA, aadB, catA, ant2Ia, aac6-Ib, aphA, qnr, sul1, sul2, tetA, strB, intI, and intII. blaVEB-6 was carried by a chromosomally located class I integron. For each isolate, analytical isoelectric focusing showed two β-lactamase bands at pI 5.4 (TEM-1) and 7.2 (VEB-6).

Fourteen samples (70%) contained ESC-R E. coli (n = 11), ESC-R P. mirabilis (n = 2), or both resistant species (n = 1) (Table 1). ESC-R E. coli strains found in meat originating from Switzerland possessed blaCTX-M-1 and blaCMY-2, whereas those detected in meat imported from other countries harbored blaSHV-12, blaTEM-52, or blaCMY-2. Several ESC-R E. coli isolates belonged to the same sequence type (ST), but pandemic clones (e.g., ST131) often responsible for human infections were not found (8, 9). The recorded high prevalence of ESC-R E. coli (60%) was consistent with prevalences reported in other countries (13). However, we note that in Switzerland, CTX-M-1- and CMY-2-producing E. coli strains are common colonizers of food animals and may also cause human infections (4, 6, 10).

More intriguing was the detection of ESC-R P. mirabilis that grew in MacConkey-ceftazidime and Drigalski-cefotaxime plates. In particular, one meat sample imported from Austria harbored blaCMY-2, whereas two from an unspecified European country carried blaVEB-6. These samples came from the same store and same packing plant but were wrapped on different dates.

CMY-2-positive P. mirabilis isolates are commonly found in humans (11), but only unique VEB-6-possessing P. mirabilis isolates had been previously reported as responsible for infection in France, Oman, and Australia (7, 12, 13). In our isolates, blaVEB-6 was situated in an ∼17-kb class I integron which also carried aacA4, aadB, dfrA1, sul1, tet(A), and qnrA1 resistance genes and had a nucleotide sequence identical to that found in the human VEB-6-positive P. mirabilis isolate (VB1248) reported in France (12). Both VEB-6-positive P. mirabilis isolates also possessed a previously reported class II integron of ∼4.6 kb containing dfrA1, sat2, and aadA1 resistance genes (GenBank no. DQ268533) and a single ∼50-kb IncP plasmid. Electroporation experiments failed to transfer blaVEB-6, suggesting the chromosomal location of the integron. By repetitive extragenic palindromic PCR (rep-PCR), the two VEB-6-positive P. mirabilis isolates were identical to each other and showed 94% genomic identity with VB1248. Based on these results, we investigated the possible presence of VEB-6-positive P. mirabilis among 484 human isolates identified in Bern during 2011-2012, and we identified only four CMY-2-positive P. mirabilis isolates which were not clonally related to those found in poultry meat (see Fig. S1 in the supplemental material).

This is the first report of blaVEB-possessing P. mirabilis in a non-human clinical setting and the first description of ESBL- and pAmpC-positive P. mirabilis strains in the food chain. Our findings emphasize that not only ESC-R E. coli but also other species are responsible for the spread of multidrug-resistant mobile genetic elements in the raw meat. CMY-2- and VEB-6-positive P. mirabilis strains might represent an additional group of life-threatening pathogens that can be transmitted through the food chain to humans (8).

Supplementary Material

Supplemental material

ACKNOWLEDGMENTS

We thank Sara Droz and Alexandra Collaud for advice and technical assistance.

This work was supported by internal funds of the Institute of Infectious Diseases of Bern (IFIK) and by grant 1.12.06 (2012–2014) from the Swiss Veterinary Federal Office (BVET). Salome N. Seiffert is a Ph.D. student supported by IFIK and BVET.

Footnotes

Published ahead of print 30 September 2013

Supplemental material for this article may be found at http://dx.doi.org/10.1128/AAC.01773-13.

REFERENCES

  • 1. Kola A, Kohler C, Pfeifer Y, Schwab F, Kuhn K, Schulz K, Balau V, Breitbach K, Bast A, Witte W, Gastmeier P, Steinmetz I. 2012. High prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, Germany. J. Antimicrob. Chemother. 67:2631–2634 [DOI] [PubMed] [Google Scholar]
  • 2. Egea P, Lopez-Cerero L, Torres E, del Gomez-Sanchez MC, Serrano L, Navarro Sanchez-Ortiz MD, Rodriguez-Bano J, Pascual A. 2012. Increased raw poultry meat colonization by extended spectrum β-lactamase-producing Escherichia coli in the south of Spain. Int. J. Food Microbiol. 159:69–73 [DOI] [PubMed] [Google Scholar]
  • 3. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ. 2011. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin. Microbiol. Infect. 17:873–880 [DOI] [PubMed] [Google Scholar]
  • 4. Seiffert SN, Hilty M, Kronenberg A, Droz S, Perreten V, Endimiani A. 2013. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland. J. Antimicrob. Chemother. 68:2249–2254 [DOI] [PubMed] [Google Scholar]
  • 5. Hilty M, Betsch BY, Bögli-Stuber K, Heiniger N, Stadler M, Kuffer M, Kronenberg A, Rohrer C, Aebi S, Endimiani A, Droz S, Mühlemann K. 2012. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin. Infect. Dis. 55:967–975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Endimiani A, Rossano A, Kunz D, Overesch G, Perreten V. 2012. First countrywide survey of third-generation cephalosporin-resistant Escherichia coli from broilers, swine, and cattle in Switzerland. Diagn. Microbiol. Infect. Dis. 73:31–38 [DOI] [PubMed] [Google Scholar]
  • 7. Zong Z, Partridge SR, Iredell JR. 2009. A blaVEB-1 variant, blaVEB-6, associated with repeated elements in a complex genetic structure. Antimicrob. Agents Chemother. 53:1693–1697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Seiffert SN, Hilty M, Perreten V, Endimiani A. 2013. Extended-spectrum cephalosporin-resistant gram-negative organisms in livestock: an emerging problem for human health? Drug Resist. Updat. 16:22–45 [DOI] [PubMed] [Google Scholar]
  • 9. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736–755 [DOI] [PubMed] [Google Scholar]
  • 10. Endimiani A, Hilty M, Perreten V. 2012. CMY-2-producing Escherichia coli in the nose of pigs. Antimicrob. Agents Chemother. 56:4556–4557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. D'Andrea MM, Literacka E, Zioga A, Giani T, Baraniak A, Fiett J, Sadowy E, Tassios PT, Rossolini GM, Gniadkowski M, Miriagou V. 2011. Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe. Antimicrob. Agents Chemother. 55:2735–2742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Siebor E, Neuwirth C. 2011. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region. J. Antimicrob. Chemother. 66:2513–2520 [DOI] [PubMed] [Google Scholar]
  • 13. Potron A, Poirel L, Elhag K, Al Yaqoubi F, Nordmann P. 2009. VEB-6 extended-spectrum β-lactamase-producing Proteus mirabilis from Sultanate of Oman. Int. J. Antimicrob. Agents 34:493–494 [DOI] [PubMed] [Google Scholar]
  • 14. EUCAST 2013. European Committee on Antimicrobial Susceptibility Testing clinical breakpoints. Version 3.0 [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental material

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES